CEFADROXIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cefadroxil, and what generic alternatives are available?
Cefadroxil is a drug marketed by Aurobindo Pharma, Chartwell Rx, Cspc Ouyi, Hikma, Ivax Sub Teva Pharms, Lupin, Purepac Pharm, Ranbaxy Labs Ltd, Sandoz, Teva, Teva Pharms, Ani Pharms, Apothecon, Aurobindo, Hikma Pharms, Sun Pharm Inds Ltd, and Ranbaxy. and is included in twenty-three NDAs.
The generic ingredient in CEFADROXIL is cefadroxil/cefadroxil hemihydrate. Nineteen suppliers are listed for this compound. Additional details are available on the cefadroxil/cefadroxil hemihydrate profile page.
Summary for CEFADROXIL
| US Patents: | 0 |
| Applicants: | 17 |
| NDAs: | 23 |
| Finished Product Suppliers / Packagers: | 19 |
| Raw Ingredient (Bulk) Api Vendors: | 69 |
| Clinical Trials: | 11 |
| Patent Applications: | 6,246 |
| Drug Prices: | Drug price information for CEFADROXIL |
| DailyMed Link: | CEFADROXIL at DailyMed |
Recent Clinical Trials for CEFADROXIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Rothman Institute Orthopaedics | Phase 3 |
| University of Colorado, Denver | Phase 1 |
| National University Hospital, Singapore | Phase 2 |
Pharmacology for CEFADROXIL
| Drug Class | Cephalosporin Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for CEFADROXIL
US Patents and Regulatory Information for CEFADROXIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | CEFADROXIL | cefadroxil/cefadroxil hemihydrate | TABLET;ORAL | 065260-001 | Mar 30, 2006 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Sun Pharm Inds Ltd | CEFADROXIL | cefadroxil/cefadroxil hemihydrate | FOR SUSPENSION;ORAL | 065115-001 | Mar 26, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Ranbaxy | CEFADROXIL | cefadroxil/cefadroxil hemihydrate | TABLET;ORAL | 065018-001 | Apr 23, 1999 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Sun Pharm Inds Ltd | CEFADROXIL | cefadroxil/cefadroxil hemihydrate | FOR SUSPENSION;ORAL | 065115-002 | Mar 26, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
